VCELVericel Corporation

$2B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$31M+34.2% YoY

Gross Profit

$23M72.5% margin

Operating Income

$6M19.1% margin

Net Income

$5M16.7% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

+39.4%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$2M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$119M

Total Liabilities

$16M

Stockholders' Equity

$102M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$23M	+34.2%
Gross Profit	$23M	$15M	+51.8%
Operating Income	$6M	$1M	+403.4%
Net Income	$5M	$287,000	+1726.5%

VCEL Q4 2018 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena